J&J reported $15.38B in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
AbbVie USD 5.31B 178M Sep/2026
Abbott USD 7.34B 22M Sep/2026
Amgen USD 6.39B 169M Sep/2026
AstraZeneca USD 6.93B 362M Jun/2026
Baxter International USD 2.3B 41M Sep/2026
Bayer EUR 11.97B 43M Jun/2026
Becton, Dickinson and Co. USD 3.19B 125M Sep/2026
Biogen USD 2.22B 159.9M Sep/2026
Boston Scientific USD 3.32B 82M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
CONMED USD 362.83M 2.65M Sep/2026
Cooper Companies USD 896.4M 20M Mar/2026
Dexcom USD 770.7M 44.3M Sep/2026
Edwards Lifesciences USD 1.16B 28.2M Sep/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Gilead Sciences USD 1.9B 57M Sep/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
Globus Medical USD 824.14M 13.25M Sep/2026
Insulet USD 552.1M 67.3M Sep/2026
Integra LifeSciences USD 464.45M 27.55M Sep/2026
Intuitive Surgical USD 2.13B 99.5M Sep/2026
J&J USD 15.38B 233M Sep/2026
Medtronic USD 6.22B 264M Jun/2026
Merck USD 6.16B 43M Sep/2026
Merit Medical Systems USD 391.02M 16.91M Sep/2026
Novartis USD 6.1B 116M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Regeneron Pharmaceuticals USD 2.89B 189.7M Sep/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
Stryker USD 5.75B 226M Sep/2026
Tandem Diabetes Care USD 143.12M 8.01M Sep/2026
Teva Pharmaceutical Industries USD 3.17B 48M Sep/2026
Vertex Pharmaceuticals USD 2.25B 480.2M Sep/2026
Zimmer Biomet Holdings USD 2.37B 96.9M Sep/2026
Zoetis USD 2.54B 38M Sep/2026